{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":25,"n_cols":5,"rows_kept":25,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[12,2,12,3],[13,2,13,3],[17,2,17,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910829935303321"]
[null,null,"Titolo",null,"Cost containment and efficiency in national health systems [[electronic resource] ] : a global comparison / / edited by John Rapoport, Philip Jacobs, and Egon Jonsson"]
[null,null,"Pubbl/distr/stampa",null,"Weinheim, : Wiley-Blackwell, c2009"]
[null,null,"ISBN",null,"1-282-02132-X"]
[{"$nulls":4},"9786612021329"]
[{"$nulls":4},"3-527-62296-9"]
[{"$nulls":4},"3-527-62295-0"]
[null,null,"Descrizione fisica",null,"1 online resource (249 p.)"]
[null,null,"Collana",null,"Health care and disease management"]
[null,null,"Disciplina",null,"362.1"]
[null,null,"Soggetti",null,"Health services administration - Finance"]
[{"$nulls":4},"Medical policy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Cost Containment and Efficiency in National Health Systems: A Global Comparison; Contents; Preface; List of Contributors; 1 Introduction and Summary; 1.1 Introduction; 1.2 Highlights of Each Country's Approach; 1.3 How Are Cost Containment and Efficiency Related?; 1.4 Strategies and Their Effects: A Cross-Country Analysis; 1.5 Current Policy Agenda; References; 2 Canada; 2.1 Canada's Health Care System; 2.1.1 Paying for Canadian Health Care; 2.1.2 Delivering Health Care in Canada; 2.1.3 Overall Expenditure Trends; 2.1.4 Cost Control Strategies Employed; 2.2 Supply-Side Measures"]
[{"$nulls":4},"2.2.1 Capped Budgets2.2.1.1 Hospitals; 2.2.1.2 Physicians; 2.2.1.3 Pharmaceuticals; 2.2.2 Health Human Resource Limits; 2.2.2.1 Physicians; 2.2.2.2 Other Health Care Professionals; 2.3 Organizational Reforms: Trade-Offs Between Competition and Cooperation; 2.3.1 Cooperation: Regional Authorities; 2.3.2 Cooperation: Primary Care Reform; 2.3.3 Waiting Time Strategies; 2.3.4 Competition; 2.4 Demand-Side Measures; 2.4.1 Technology Assessment/Appropriateness; 2.4.2 Population Health; 2.5 The Current Situation; References; 3 England; 3.1 Introduction; 3.2 The Structural Characteristics of the NHS"]
[{"$nulls":4},"3.3 The Efficiency Initiatives3.3.1 The Internal Market; 3.3.2 The National Institute for Health and Clinical Excellence; 3.3.3 Performance "]
[{"$nulls":4},"Management; 3.3.4 Patient Choice; 3.4 Conclusions; References; 4 Finland; 4.1 Introduction; 4.2 The Finnish Health Care System; 4.2.1 Structure; 4.2.2 Trends in Cost and Financing; 4.3 Strategies for Municipal Health Services; 4.3.1 Decentralization of Responsibilities; 4.3.2 Governments Strategic Planning; 4.3.3 Cost Containment at the Local Level; 4.3.4 Increasing the Size of Municipalities; 4.3.5 Evaluation of the Strategies"]
[{"$nulls":4},"4.4 Cost Containment in Services Covered by NHI4.4.1 The Finnish Pharmaceutical System; 4.4.2 Cost-Containment Measures; 4.4.2.1 Cost Sharing and Price Control; 4.4.2.2 Generic Substitution; 4.4.2.3 Other Measures; 4.4.3 Evaluation of Strategies; 4.4.3.1 Total Expenditure on Drugs; 4.4.3.2 Development of Prices; 4.4.3.3 The Effect of Generic Substitution; 4.5 Lessons from Finland; References; 5 Germany; 5.1 A Review of the Major Structural and Operational Characteristics of the German Health Care System; 5.1.1 Key Aspects of Sickness Funds and Providers of Health Care"]
[{"$nulls":4},"5.1.2 Key Aspects on Financing of Health Care5.2 Major Cost-Containment and Efficiency-Seeking Strategies; 5.2.1 Global Budgets and Spending Caps; 5.2.1.1 Pharmaceuticals; 5.2.1.2 Ambulatory Care; 5.2.1.3 Hospital Care; 5.2.1.4 Financial and Other Performance Indicators of SHI Ambulatory Physician Practices and Hospitals; 5.2.2 Cost Shifts to Private Households; 5.2.3 Promoting Competition between Sickness Funds and Providers; 5.2.4 Strengthening the Competencies of Joint Self-Government; 5.2.5 Summarizing and Concluding Remarks on Cost Containment and Efciency Seeking Strategies"]
[{"$nulls":4},"5.3 Report on the Current Situation"]
[null,null,null,"Sommario/riassunto","Written by a local health economics expert, each of the eight chapters in this timely handbook and ready reference describes the national healthcare system of a different industrialized country. In each case, the 4-5 specific policies with the highest impact on that respective country over the past 20-30 years are identified. In addition, the economic characteristics of each policy are described and, where possible, its success evaluated, discussing the current policy agenda. A final chapter summarizes and synthesizes the major points of the analysis. While the main focus is on economics,"]